Sopherion Therapeutics, Inc.

Scott Smith , Celgene Corp. ’s president and chief operating officer, is leaving the company, effective immediately. His abrupt departure follows a series of product setbacks for the firm, and his m

The past year has been a rollercoaster of a ride for the private investment market. The US continues to lead the way by a long shot, although robust business strategies have allowed some European biot

Private investments in pharmaceutical and biotech companies took a healthy leap last month as the funds raised increased by 30% to $273.9 million, compared with January, a Scrip analysis has found.

Analyzing the venture financings closed by 2004's new crop of biotech, diagnostics, and medical device start-ups reveals today's trends that may shape tomorrow's health care industry. The return of th